Pub Date : 2025-12-01Epub Date: 2025-11-12DOI: 10.1016/j.nmni.2025.101664
Fatemeh Sameni , Ali Dadashi , Bahareh Hajikhani , Maedeh Pourali Eshkalak , Alex van Belkum , Ali Hashemi , Azadeh Alirezaei , Masoud Dadashi
Background
Infections caused by Stenotrophomonas maltophilia (S. maltophilia) are particularly difficult to treat because of their intrinsic resistance to multiple antibiotics.
Objective
The main aim of this systematic review was to evaluate the prevalence of infections caused by this bacterium across different provinces of Iran. Additionally, the study assessed the resistance rates of commonly prescribed antibiotics to address existing gaps in therapeutic knowledge.
Methods
A systematic literature review was conducted to identify relevant original research articles published in English between 2000 and 2024, using Google Scholar, Medline (via PubMed), Embase, and Web of Science. Following screening, all studies reporting antibiotic resistance in clinical isolates of S. maltophilia from Iran were included and analyzed.
Results
A total of 1415 clinical isolates were collected from 16 regions across Iran. Most isolates showed high susceptibility to ticarcillin/clavulanic acid and minocycline (98.5 % and 98.2 %, respectively). Among the genes associated with biofilm formation and antibiotic resistance, sul1 and spgM were the most prevalent (12.4 % and 39.6 %, respectively).
Conclusion
Given the low resistance rates to levofloxacin and minocycline, these antibiotics may be considered as potentially effective options for treating S. maltophilia infections in Iran. Trimethoprim-sulfamethoxazole showed comparatively higher resistance rates, suggesting that its clinical efficacy may be declining. The rising isolation of S. maltophilia from clinical specimens in recent years, compared to the previous decade, is of both epidemiological and clinical concern, highlighting the need for ongoing surveillance and prudent antibiotic use.
嗜麦芽窄养单胞菌(S. maltopophilia)引起的感染尤其难以治疗,因为它们对多种抗生素具有内在耐药性。目的本系统综述的主要目的是评估伊朗不同省份由该细菌引起的感染的流行情况。此外,该研究评估了常用抗生素的耐药率,以解决治疗知识方面的现有空白。方法利用谷歌Scholar、Medline(通过PubMed)、Embase和Web of Science,对2000 - 2024年间发表的相关英文原创研究文章进行系统的文献综述。筛选后,纳入并分析了所有报道伊朗嗜麦芽葡萄球菌临床分离株抗生素耐药性的研究。结果在伊朗16个地区共采集到临床分离株1415株。大多数菌株对替卡西林/克拉维酸和米诺环素的敏感性分别为98.5%和98.2%。在与生物膜形成和抗生素耐药性相关的基因中,sul1和spgM最为普遍(分别占12.4%和39.6%)。结论考虑到左氧氟沙星和米诺环素的低耐药率,这些抗生素可能被认为是治疗伊朗嗜麦芽葡萄球菌感染的潜在有效选择。甲氧苄啶-磺胺甲恶唑耐药率较高,提示其临床疗效可能正在下降。与过去十年相比,近年来从临床标本中分离出嗜麦芽链球菌的情况越来越多,这是流行病学和临床关注的问题,突出了持续监测和谨慎使用抗生素的必要性。
{"title":"Insights into antibiotic resistance and prevalence of Stenotrophomonas maltophilia isolated from clinical samples in Iran: A systematic review","authors":"Fatemeh Sameni , Ali Dadashi , Bahareh Hajikhani , Maedeh Pourali Eshkalak , Alex van Belkum , Ali Hashemi , Azadeh Alirezaei , Masoud Dadashi","doi":"10.1016/j.nmni.2025.101664","DOIUrl":"10.1016/j.nmni.2025.101664","url":null,"abstract":"<div><h3>Background</h3><div>Infections caused by <em>Stenotrophomonas maltophilia</em> (<em>S. maltophilia</em>) are particularly difficult to treat because of their intrinsic resistance to multiple antibiotics.</div></div><div><h3>Objective</h3><div>The main aim of this systematic review was to evaluate the prevalence of infections caused by this bacterium across different provinces of Iran. Additionally, the study assessed the resistance rates of commonly prescribed antibiotics to address existing gaps in therapeutic knowledge.</div></div><div><h3>Methods</h3><div>A systematic literature review was conducted to identify relevant original research articles published in English between 2000 and 2024, using Google Scholar, Medline (via PubMed), Embase, and Web of Science. Following screening, all studies reporting antibiotic resistance in clinical isolates of <em>S. maltophilia</em> from Iran were included and analyzed.</div></div><div><h3>Results</h3><div>A total of 1415 clinical isolates were collected from 16 regions across Iran. Most isolates showed high susceptibility to ticarcillin/clavulanic acid and minocycline (98.5 % and 98.2 %, respectively). Among the genes associated with biofilm formation and antibiotic resistance, <em>sul1</em> and <em>spgM</em> were the most prevalent (12.4 % and 39.6 %, respectively).</div></div><div><h3>Conclusion</h3><div>Given the low resistance rates to levofloxacin and minocycline, these antibiotics may be considered as potentially effective options for treating <em>S. maltophilia</em> infections in Iran. Trimethoprim-sulfamethoxazole showed comparatively higher resistance rates, suggesting that its clinical efficacy may be declining. The rising isolation of <em>S. maltophilia</em> from clinical specimens in recent years, compared to the previous decade, is of both epidemiological and clinical concern, highlighting the need for ongoing surveillance and prudent antibiotic use.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101664"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145683612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-21DOI: 10.1016/j.nmni.2025.101676
Jie Liu , Kaiming Zhang , Rui Yu , Haozhi Han , Peng Zhao
<div><h3>Background</h3><div>Osteoarticular fungal infections (OAFIs), including fungal osteomyelitis and septic arthritis, represent uncommon but clinically significant complications in musculoskeletal care. Current management remains challenging due to limited evidence guiding antifungal selection. This study aims to characterize the epidemiological patterns, clinical features, and antifungal susceptibility profiles of OAFIs, with particular focus on the critical role of <em>in vitro</em> susceptibility testing in determining treatment outcomes.</div></div><div><h3>Methods</h3><div>A retrospective study of patients was conducted with OAFIs treated between January 2020 and February 2024, analyzing clinical manifestations, surgical interventions, and associated risk factors. Fungal identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), followed by broth microdilution antifungal susceptibility testing for amphotericin B (AMB), fluconazole (FLC), voriconazole (VRC), and posaconazole (POS). Minimum inhibitory concentration (MIC) values were interpreted according to CLSI guidelines to determine susceptibility profiles and identify potential resistance mechanisms.</div></div><div><h3>Results</h3><div>Sixty fungal isolates were isolated from 60 patients with OAFIs including <em>Candida</em> spp. (n = 40, 66.7 %), <em>Aspergillus</em> spp. (n = 14, 23.3 %), <em>Cryptococcus neoformans</em> (n = 2, 3.3 %), <em>Trichophyton rubrum</em> (n = 2, 3.3 %), <em>Lomentospora prolificans</em> (n = 1, 1.7 %), and <em>Cryptococcus laurentii</em> (n = 1, 1.7 %). The isolates were obtained from joint fluid (n = 48, 80 %) and inflammatory lesions (n = 12, 20 %). Antifungal susceptibility testing demonstrated highest MIC values for FLC but susceptibility profiles for VRC and POS against all fungal isolates. Statistical analysis revealed significant differences in VRC and POS activity among <em>Candida</em>, <em>Aspergillus</em>, and <em>Cryptococcus</em> spp. (F = 15.78, <em>P</em> < 0.01; F = 66.88, <em>P</em> < 0.0001). VRC activity did not differ between <em>Candida</em> and <em>Aspergillus</em> spp., but both were lower than against <em>Cryptococcus</em> spp. (<em>P</em> < 0.05 and <em>P</em> < 0.05). POS activity was higher against <em>Candida</em> than <em>Aspergillus</em> (<em>P</em> < 0.001) and <em>Cryptococcus</em> spp. (<em>P</em> < 0.0001), and higher against <em>Cryptococcus</em> than <em>Aspergillus</em> (<em>P</em> < 0.05). Systemic comorbidities were common (73.3 %), one patient was HIV-positive, and three had only localized superficial fungal infections.</div></div><div><h3>Conclusion</h3><div>We concluded that <em>Candida albicans</em> and <em>Aspergillus fumigatus</em> as the predominant pathogens in OAFIs, while rare species including <em>Cryptococcus neoformans</em>, <em>Lomentospora prolificans</em>, and <em>Cryptococcus laurentii</em> were also isolated
骨关节真菌感染(OAFIs),包括真菌性骨髓炎和脓毒性关节炎,是肌肉骨骼护理中不常见但临床上重要的并发症。目前的管理仍然具有挑战性,因为指导抗真菌选择的证据有限。本研究旨在描述OAFIs的流行病学模式、临床特征和抗真菌药敏特征,特别关注体外药敏试验在确定治疗结果中的关键作用。方法回顾性分析2020年1月至2024年2月期间接受OAFIs治疗的患者的临床表现、手术干预及相关危险因素。采用基质辅助激光解吸/电离飞行时间质谱法(MALDI-TOF MS)进行真菌鉴定,随后进行肉汤微量稀释对两性霉素B (AMB)、氟康唑(FLC)、伏立康唑(VRC)和泊沙康唑(POS)的抗真菌药敏试验。根据CLSI指南解释最低抑制浓度(MIC)值,以确定敏感性概况并确定潜在的耐药机制。结果从60例OAFIs患者中分离到真菌60株,其中念珠菌40株(66.7%)、曲霉菌14株(23.3%)、新型隐球菌2株(3.3%)、红毛癣菌2株(3.3%)、增殖性卷孢菌1株(1.7%)、劳伦隐球菌1株(1.7%)。分离株分别来自关节液(n = 48, 80%)和炎性病变(n = 12, 20%)。抗真菌药敏试验表明,FLC的MIC值最高,但VRC和POS对所有真菌分离株的药敏曲线最高。统计分析显示,假丝酵母菌、曲霉菌和隐球菌的VRC和POS活性差异有统计学意义(F = 15.78, P < 0.01; F = 66.88, P < 0.0001)。VRC活性在假丝酵母菌和曲霉菌间无显著差异,但均低于隐球菌(P <; 0.05和P <; 0.05)。POS对假丝酵母菌的活性高于曲霉菌(P < 0.001)和隐球菌(P < 0.0001),对隐球菌的活性高于曲霉菌(P < 0.05)。全身合并症很常见(73.3%),1例hiv阳性,3例仅局部浅表真菌感染。结论OAFI的主要病原菌为白色念珠菌和烟曲霉,同时也检出了新型隐球菌、增殖性绵孢子菌和劳伦隐球菌等稀有病原菌。抗真菌药敏试验显示VRC和POS是OAFIs潜在有效的治疗选择。这些发现强调了早期发现罕见真菌病原体、敏感性指导治疗和持续耐药性监测对非免疫缺陷患者OAFIs治疗的必要性。
{"title":"Species distribution, antifungal susceptibility, and clinical profiles of patients with osteoarticular fungal Infections: A retrospective study","authors":"Jie Liu , Kaiming Zhang , Rui Yu , Haozhi Han , Peng Zhao","doi":"10.1016/j.nmni.2025.101676","DOIUrl":"10.1016/j.nmni.2025.101676","url":null,"abstract":"<div><h3>Background</h3><div>Osteoarticular fungal infections (OAFIs), including fungal osteomyelitis and septic arthritis, represent uncommon but clinically significant complications in musculoskeletal care. Current management remains challenging due to limited evidence guiding antifungal selection. This study aims to characterize the epidemiological patterns, clinical features, and antifungal susceptibility profiles of OAFIs, with particular focus on the critical role of <em>in vitro</em> susceptibility testing in determining treatment outcomes.</div></div><div><h3>Methods</h3><div>A retrospective study of patients was conducted with OAFIs treated between January 2020 and February 2024, analyzing clinical manifestations, surgical interventions, and associated risk factors. Fungal identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), followed by broth microdilution antifungal susceptibility testing for amphotericin B (AMB), fluconazole (FLC), voriconazole (VRC), and posaconazole (POS). Minimum inhibitory concentration (MIC) values were interpreted according to CLSI guidelines to determine susceptibility profiles and identify potential resistance mechanisms.</div></div><div><h3>Results</h3><div>Sixty fungal isolates were isolated from 60 patients with OAFIs including <em>Candida</em> spp. (n = 40, 66.7 %), <em>Aspergillus</em> spp. (n = 14, 23.3 %), <em>Cryptococcus neoformans</em> (n = 2, 3.3 %), <em>Trichophyton rubrum</em> (n = 2, 3.3 %), <em>Lomentospora prolificans</em> (n = 1, 1.7 %), and <em>Cryptococcus laurentii</em> (n = 1, 1.7 %). The isolates were obtained from joint fluid (n = 48, 80 %) and inflammatory lesions (n = 12, 20 %). Antifungal susceptibility testing demonstrated highest MIC values for FLC but susceptibility profiles for VRC and POS against all fungal isolates. Statistical analysis revealed significant differences in VRC and POS activity among <em>Candida</em>, <em>Aspergillus</em>, and <em>Cryptococcus</em> spp. (F = 15.78, <em>P</em> < 0.01; F = 66.88, <em>P</em> < 0.0001). VRC activity did not differ between <em>Candida</em> and <em>Aspergillus</em> spp., but both were lower than against <em>Cryptococcus</em> spp. (<em>P</em> < 0.05 and <em>P</em> < 0.05). POS activity was higher against <em>Candida</em> than <em>Aspergillus</em> (<em>P</em> < 0.001) and <em>Cryptococcus</em> spp. (<em>P</em> < 0.0001), and higher against <em>Cryptococcus</em> than <em>Aspergillus</em> (<em>P</em> < 0.05). Systemic comorbidities were common (73.3 %), one patient was HIV-positive, and three had only localized superficial fungal infections.</div></div><div><h3>Conclusion</h3><div>We concluded that <em>Candida albicans</em> and <em>Aspergillus fumigatus</em> as the predominant pathogens in OAFIs, while rare species including <em>Cryptococcus neoformans</em>, <em>Lomentospora prolificans</em>, and <em>Cryptococcus laurentii</em> were also isolated ","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101676"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145614251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
After COVID-19 emerged, hospitals adopted preadmission screening to detect asymptomatic cases and avert nosocomial outbreaks; whether such clinical screening should be routine policy remains debated and has not been quantified in Japan.
Objective
To evaluate preadmission clinical screening as a component of pandemic preparedness.
Methods
The primary outcome was positivity on preadmission screening. We modeled COVID-19 positivity among asymptomatic preadmission patients using regression and a Tobit specification to accommodate excess zeros, then developed a predictive model. Analyses used hospital data linked to prefecture-level indicators of community transmission, including newly confirmed cases and influenza-like-illness (ILI) sentinel activity.
Results
In this single-center retrospective study, 5897 newly confirmed COVID-19 cases were analyzed at the hospital. During the same period, Mie Prefecture reported 355,879 cases overall, including 45,551 visits to ILI sentinel sites. In 2022, screening positivity among asymptomatic preadmission patients correlated strongly with the number of newly confirmed cases in the prefecture. The model predicted non-zero screening positivity when newly confirmed prefectural cases exceeded ∼10,000, regardless of assumed ILI positivity. When prefectural cases were <2,000, predicted screening positivity was ∼0 even if assumed ILI positivity was ∼40 %.
Discussion and conclusions
Findings suggest conditions for conducting preadmission clinical screening during the COVID-19 pandemic, which can support healthcare infrastructure preparedness against pandemics of novel infectious diseases.
{"title":"Association between positive preadmission screening and COVID-19 community transmission: A retrospective observational study during an emergent novel infectious disease pandemic","authors":"Shingo Mitsushima , Yasushi Ohkusa , Kiyosu Taniguchi , Yasuharu Tokuda , Kenji Shibuya","doi":"10.1016/j.nmni.2025.101647","DOIUrl":"10.1016/j.nmni.2025.101647","url":null,"abstract":"<div><h3>Background</h3><div>After COVID-19 emerged, hospitals adopted preadmission screening to detect asymptomatic cases and avert nosocomial outbreaks; whether such clinical screening should be routine policy remains debated and has not been quantified in Japan.</div></div><div><h3>Objective</h3><div>To evaluate preadmission clinical screening as a component of pandemic preparedness.</div></div><div><h3>Methods</h3><div>The primary outcome was positivity on preadmission screening. We modeled COVID-19 positivity among asymptomatic preadmission patients using regression and a Tobit specification to accommodate excess zeros, then developed a predictive model. Analyses used hospital data linked to prefecture-level indicators of community transmission, including newly confirmed cases and influenza-like-illness (ILI) sentinel activity.</div></div><div><h3>Results</h3><div>In this single-center retrospective study, 5897 newly confirmed COVID-19 cases were analyzed at the hospital. During the same period, Mie Prefecture reported 355,879 cases overall, including 45,551 visits to ILI sentinel sites. In 2022, screening positivity among asymptomatic preadmission patients correlated strongly with the number of newly confirmed cases in the prefecture. The model predicted non-zero screening positivity when newly confirmed prefectural cases exceeded ∼10,000, regardless of assumed ILI positivity. When prefectural cases were <2,000, predicted screening positivity was ∼0 even if assumed ILI positivity was ∼40 %.</div></div><div><h3>Discussion and conclusions</h3><div>Findings suggest conditions for conducting preadmission clinical screening during the COVID-19 pandemic, which can support healthcare infrastructure preparedness against pandemics of novel infectious diseases.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101647"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145321044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-19DOI: 10.1016/j.nmni.2025.101668
Qiuyu Zhang , Ge Zhang , Yongbin Zhai , Qi Zhao , Yaru Feng , Maraba Rawaydul , Yuyu Zhang , Xiaolong Jiao , Yang Zhang , Yuefeng Chu , Jian Xu , Duoliang Ran , Bin Li
In April 2023, outbreaks of a novel oral disease were observed in Bactrian camels in Altay Prefecture, Xinjiang, China. To clarify the etiology and epidemiology, we surveyed 1863 camels from 12 farms across three major camel-producing counties. A total of 311 camels (16.7 %) exhibited characteristic lesions, with significantly higher incidence in adults (18.1 %) than juveniles (9.7 %) (p < 0.05). Tissue samples from 12 clinically affected camels were subjected to PCR testing for multiple poxviruses. Only Camel Contagious Ecthyma Virus (CCEV) was detected, and sequencing of the B2L gene confirmed its identity. Phylogenetic analysis revealed that Xinjiang isolates shared >98 % nucleotide homology with strains from Saudi Arabia and Sudan, with no variation among the 12 local sequences. Histopathology showed epidermal necrosis, hyperplasia, and intracytoplasmic inclusion bodies, consistent with parapoxvirus infection, and electron microscopy revealed typical poxvirus morphology. These findings document the first confirmed detection and molecular characterization of CCEV in camels in China, highlighting its potential impact on the camel industry and the need for further investigation of its epidemiology and zoonotic risk.
{"title":"First identification of camel Contagious Ecthyma Virus in camels from Altay, Xinjiang, China","authors":"Qiuyu Zhang , Ge Zhang , Yongbin Zhai , Qi Zhao , Yaru Feng , Maraba Rawaydul , Yuyu Zhang , Xiaolong Jiao , Yang Zhang , Yuefeng Chu , Jian Xu , Duoliang Ran , Bin Li","doi":"10.1016/j.nmni.2025.101668","DOIUrl":"10.1016/j.nmni.2025.101668","url":null,"abstract":"<div><div>In April 2023, outbreaks of a novel oral disease were observed in Bactrian camels in Altay Prefecture, Xinjiang, China. To clarify the etiology and epidemiology, we surveyed 1863 camels from 12 farms across three major camel-producing counties. A total of 311 camels (16.7 %) exhibited characteristic lesions, with significantly higher incidence in adults (18.1 %) than juveniles (9.7 %) (<em>p</em> < 0.05). Tissue samples from 12 clinically affected camels were subjected to PCR testing for multiple poxviruses. Only <em>Camel Contagious Ecthyma Virus</em> (CCEV) was detected, and sequencing of the B2L gene confirmed its identity. Phylogenetic analysis revealed that Xinjiang isolates shared >98 % nucleotide homology with strains from Saudi Arabia and Sudan, with no variation among the 12 local sequences. Histopathology showed epidermal necrosis, hyperplasia, and intracytoplasmic inclusion bodies, consistent with parapoxvirus infection, and electron microscopy revealed typical poxvirus morphology. These findings document the first confirmed detection and molecular characterization of CCEV in camels in China, highlighting its potential impact on the camel industry and the need for further investigation of its epidemiology and zoonotic risk.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101668"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145568713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-09-04DOI: 10.1016/j.nmni.2025.101637
Chiranjib Chakraborty , Manojit Bhattacharya , Arpita Das , Rao Zahid Abbas , Priyanka Choudhary , Om Prakash Choudhary
{"title":"Current status of H5N1 influenza vaccines against clade 2.3.4.4b of H5N1","authors":"Chiranjib Chakraborty , Manojit Bhattacharya , Arpita Das , Rao Zahid Abbas , Priyanka Choudhary , Om Prakash Choudhary","doi":"10.1016/j.nmni.2025.101637","DOIUrl":"10.1016/j.nmni.2025.101637","url":null,"abstract":"","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101637"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-08DOI: 10.1016/j.nmni.2025.101659
Darío S. López-Delgado , Carlos A. Narváez , Roberto Bonfante-Villalobos , Joshua Emmanuel Arteaga , Hector Fabio Sanchez-Galvez , Andres Ricaurte-Fajardo , Lysien Zambrano , Alfonso J. Rodriguez-Morales
Background
Strongyloides stercoralis hyperinfection syndrome (SHS) is a severe complication of strongyloidiasis, typically in immunosuppressed patients. While sepsis and multiorgan dysfunction are well recognized, the association with thrombotic complications remains underexplored.
Methods
We conducted a systematic review of case reports and case series following PRISMA 2020 guidelines. PubMed, Embase, Scopus, Web of Science, and Google Scholar were searched through December 2024. Eligible studies included patients with SHS or disseminated strongyloidiasis and confirmed thrombotic events. Data on demographics, risk factors, infection characteristics, thrombosis, treatment, and outcomes were extracted and narratively synthesized.
Results
Fourteen studies describing 16 cases of SHS with thrombosis published between 2013 and 2024 were included. Median age was 66 years (range 40–87), with a slight male predominance. Most patients (68.8%) were immunosuppressed, primarily due to corticosteroid therapy. Thrombotic events were heterogeneous, including deep vein thrombosis, pulmonary embolism, portal and renal vein thrombosis, intracardiac thrombi, and disseminated intravascular coagulation. Multifocal thrombosis (arterial + venous) occurred in 3/16 (18.8%) cases; shock was present in 5/16 (31.3%). Ivermectin was the mainstay of therapy, alone or with albendazole, although treatment regimens were inconsistently reported. Anticoagulation was frequently initiated, and two cases required thrombectomy. Despite treatment, overall mortality reached 31.3%, particularly among immunosuppressed patients with shock or disseminated thrombosis.
Conclusions
SHS can be complicated by diverse and often fatal thrombotic events, especially in immunosuppressed individuals. Clinical suspicion should be heightened in patients from endemic regions or those receiving corticosteroids. Early empiric antiparasitic therapy, timely investigation for thrombotic complications, and individualized anticoagulation strategies are essential to improving outcomes. Given the reliance on case-level evidence, prospective studies and standardized reporting are urgently needed to characterize better risk factors, optimal management, and prognosis of this neglected but critical complication.
背景:粪类圆线虫过度感染综合征(SHS)是类圆线虫病的严重并发症,通常发生在免疫抑制患者中。虽然脓毒症和多器官功能障碍是公认的,但与血栓性并发症的关系仍未得到充分探讨。方法:我们按照PRISMA 2020指南对病例报告和病例系列进行了系统回顾。PubMed、Embase、Scopus、Web of Science和b谷歌Scholar的检索截止到2024年12月。符合条件的研究包括患有SHS或播散性圆线虫病并确认有血栓形成事件的患者。人口统计学、危险因素、感染特征、血栓形成、治疗和结果的数据被提取并叙述合成。结果纳入2013 - 2024年间发表的14篇文献,共16例伴有血栓形成的SHS。中位年龄66岁(40-87岁),男性稍占优势。大多数患者(68.8%)免疫抑制,主要是由于皮质类固醇治疗。血栓形成事件是异质性的,包括深静脉血栓、肺栓塞、门脉和肾静脉血栓、心内血栓和弥散性血管内凝血。多灶性血栓(动脉+静脉)3/16 (18.8%);5/16(31.3%)出现休克。伊维菌素是主要的治疗方法,单独或与阿苯达唑,尽管治疗方案的报道不一致。抗凝频繁启动,2例需要取栓。尽管接受了治疗,但总体死亡率达到31.3%,特别是在免疫抑制的休克或弥散性血栓患者中。结论shs可并发多种致死性血栓事件,尤其是免疫抑制个体。对来自流行地区的患者或接受皮质类固醇治疗的患者应加强临床怀疑。早期经验性抗寄生虫治疗、及时调查血栓性并发症和个体化抗凝策略对改善预后至关重要。鉴于对病例级证据的依赖,迫切需要前瞻性研究和标准化报告来描述这种被忽视但重要的并发症的更好的危险因素,最佳管理和预后。
{"title":"Strongyloides stercoralis hyperinfection with thrombosis: A systematic review of case reports","authors":"Darío S. López-Delgado , Carlos A. Narváez , Roberto Bonfante-Villalobos , Joshua Emmanuel Arteaga , Hector Fabio Sanchez-Galvez , Andres Ricaurte-Fajardo , Lysien Zambrano , Alfonso J. Rodriguez-Morales","doi":"10.1016/j.nmni.2025.101659","DOIUrl":"10.1016/j.nmni.2025.101659","url":null,"abstract":"<div><h3>Background</h3><div><em>Strongyloides stercoralis</em> hyperinfection syndrome (SHS) is a severe complication of strongyloidiasis, typically in immunosuppressed patients. While sepsis and multiorgan dysfunction are well recognized, the association with thrombotic complications remains underexplored.</div></div><div><h3>Methods</h3><div>We conducted a systematic review of case reports and case series following PRISMA 2020 guidelines. PubMed, Embase, Scopus, Web of Science, and Google Scholar were searched through December 2024. Eligible studies included patients with SHS or disseminated strongyloidiasis and confirmed thrombotic events. Data on demographics, risk factors, infection characteristics, thrombosis, treatment, and outcomes were extracted and narratively synthesized.</div></div><div><h3>Results</h3><div>Fourteen studies describing 16 cases of SHS with thrombosis published between 2013 and 2024 were included. Median age was 66 years (range 40–87), with a slight male predominance. Most patients (68.8%) were immunosuppressed, primarily due to corticosteroid therapy. Thrombotic events were heterogeneous, including deep vein thrombosis, pulmonary embolism, portal and renal vein thrombosis, intracardiac thrombi, and disseminated intravascular coagulation. Multifocal thrombosis (arterial + venous) occurred in 3/16 (18.8%) cases; shock was present in 5/16 (31.3%). Ivermectin was the mainstay of therapy, alone or with albendazole, although treatment regimens were inconsistently reported. Anticoagulation was frequently initiated, and two cases required thrombectomy. Despite treatment, overall mortality reached 31.3%, particularly among immunosuppressed patients with shock or disseminated thrombosis.</div></div><div><h3>Conclusions</h3><div>SHS can be complicated by diverse and often fatal thrombotic events, especially in immunosuppressed individuals. Clinical suspicion should be heightened in patients from endemic regions or those receiving corticosteroids. Early empiric antiparasitic therapy, timely investigation for thrombotic complications, and individualized anticoagulation strategies are essential to improving outcomes. Given the reliance on case-level evidence, prospective studies and standardized reporting are urgently needed to characterize better risk factors, optimal management, and prognosis of this neglected but critical complication.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101659"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145519970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-11-10DOI: 10.1016/j.nmni.2025.101662
Lamiae Bennis, Youssef Elouardi, Hamza El Aarabi, Imane Oussayeh, Mohammed Khallouki
The COVID-19 pandemic may have influenced healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), particularly in intensive care units (ICUs).
We performed a retrospective study in the ICU of Ibn Tofail Hospital, Marrakech, Morocco from March to September 2022. Patients hospitalized for more than 48 h were included. HAIs were defined according to CDC criteria, and antimicrobial susceptibility testing followed EUCAST guidelines. Results were compared with pre-pandemic data from 2019. Of 187 admitted patients, 145 were eligible, and 38 developed an HAI (26.3 %). The most frequent infections were pneumonia (37 %), catheter-related infections (27.5 %), and urinary tract infections (16.1 %). Among 112 isolates, Gram-negative bacteria predominated (82.7 %), mainly Klebsiella pneumoniae (26.8 %), Acinetobacter baumannii (17.9 %), and Pseudomonas aeruginosa (14.3 %). Compared with 2019 (98 isolates), K. pneumoniae increased significantly (17.3 % vs. 26.8 %, p = 0.048). Resistance to ceftazidime rose in P. aeruginosa (22.2 % vs. 56.3 %, p = 0.042), while methicillin resistance in Staphylococcus aureus declined (75.0 % vs. 25.0 %, p = 0.044). No significant changes were observed in carbapenem resistance. Multidrug resistance remained widespread (45.9 % vs. 50.9 %, p = 0.458).
HAIs in this ICU were mainly due to Gram-negative bacteria, with notable shifts in K. pneumoniae prevalence and specific resistance patterns after the pandemic. While multidrug resistance remains a pressing concern, most changes were limited in scope. These findings provide locally relevant data that can inform infection control and AMR surveillance strategies in North African ICUs.
COVID-19大流行可能影响了医疗保健相关感染(HAIs)和抗菌素耐药性(AMR),特别是在重症监护病房(icu)。我们于2022年3月至9月在摩洛哥马拉喀什Ibn Tofail医院的ICU进行了回顾性研究。住院时间超过48小时的患者纳入研究。HAIs根据CDC标准定义,抗菌药敏试验遵循EUCAST指南。结果与2019年大流行前的数据进行了比较。187例住院患者中,145例符合条件,38例发生HAI(26.3%)。最常见的感染是肺炎(37%)、导尿管相关感染(27.5%)和尿路感染(16.1%)。112株中以革兰氏阴性菌为主(82.7%),主要为肺炎克雷伯菌(26.8%)、鲍曼不动杆菌(17.9%)和铜绿假单胞菌(14.3%)。与2019年(98株)相比,肺炎克雷伯菌显著增加(17.3% vs. 26.8%, p = 0.048)。铜绿假单胞菌对头孢他啶的耐药性上升(22.2%比56.3%,p = 0.042),金黄色葡萄球菌对甲氧西林的耐药性下降(75.0%比25.0%,p = 0.044)。碳青霉烯类药物耐药性未见明显变化。多药耐药仍然普遍存在(45.9% vs 50.9%, p = 0.458)。该ICU的HAIs主要由革兰氏阴性菌引起,大流行后肺炎克雷伯菌患病率和特异性耐药模式发生了显著变化。虽然多药耐药仍然是一个紧迫的问题,但大多数变化的范围有限。这些发现提供了与当地相关的数据,可以为北非icu的感染控制和抗菌素耐药性监测战略提供信息。
{"title":"The impact of the COVID-19 pandemic on nosocomial infections and antimicrobial resistance (AMR) in intensive care units","authors":"Lamiae Bennis, Youssef Elouardi, Hamza El Aarabi, Imane Oussayeh, Mohammed Khallouki","doi":"10.1016/j.nmni.2025.101662","DOIUrl":"10.1016/j.nmni.2025.101662","url":null,"abstract":"<div><div>The COVID-19 pandemic may have influenced healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), particularly in intensive care units (ICUs).</div><div>We performed a retrospective study in the ICU of Ibn Tofail Hospital, Marrakech, Morocco from March to September 2022. Patients hospitalized for more than 48 h were included. HAIs were defined according to CDC criteria, and antimicrobial susceptibility testing followed EUCAST guidelines. Results were compared with pre-pandemic data from 2019. Of 187 admitted patients, 145 were eligible, and 38 developed an HAI (26.3 %). The most frequent infections were pneumonia (37 %), catheter-related infections (27.5 %), and urinary tract infections (16.1 %). Among 112 isolates, Gram-negative bacteria predominated (82.7 %), mainly <em>Klebsiella pneumoniae</em> (26.8 %), <em>Acinetobacter baumannii</em> (17.9 %), and <em>Pseudomonas aeruginosa</em> (14.3 %). Compared with 2019 (98 isolates), <em>K. pneumoniae</em> increased significantly (17.3 % vs. 26.8 %, p = 0.048). Resistance to ceftazidime rose in <em>P. aeruginosa</em> (22.2 % vs. 56.3 %, p = 0.042), while methicillin resistance in <em>Staphylococcus aureus</em> declined (75.0 % vs. 25.0 %, p = 0.044). No significant changes were observed in carbapenem resistance. Multidrug resistance remained widespread (45.9 % vs. 50.9 %, p = 0.458).</div><div>HAIs in this ICU were mainly due to Gram-negative bacteria, with notable shifts in <em>K. pneumoniae</em> prevalence and specific resistance patterns after the pandemic. While multidrug resistance remains a pressing concern, most changes were limited in scope. These findings provide locally relevant data that can inform infection control and AMR surveillance strategies in North African ICUs.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101662"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145519968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-09-26DOI: 10.1016/j.nmni.2025.101642
Aline Hajj , Hala Sacre , Maria Ounsi , Mariam Nasser , Sara Mohsen Meame , Hussein Hazime , Amal Al-Hajje , Deema Rahme , Nathalie Lahoud , Jihan Safwan , Marwan Akel , Rony M. Zeenny , Katia Iskandar , Pascale Salameh
Background
Antimicrobials have revolutionized medicine globally, but emerging antimicrobial resistance due to antimicrobial misuse might revert the world to the “pre-antibiotic era”. Research on the topic contributes to fighting antimicrobial resistance and developing related strategies. Hence, this bibliometric analysis aimed to assess antimicrobial research productivity in Lebanon.
Methods
Relevant publications were retrieved from PubMed, and data were assessed using the VOS viewer. The most research-active institutions, collaboration patterns, and various antimicrobial research areas were reported and discussed.
Results
Research productivity has exhibited an increasing trend over the past 20 years. Private institutions were the most active (90%), while international collaborations were moderate (40%), mainly with institutions in the United States and France. The only visible public-private partnership involved collaboration between the Lebanese University and other institutions. While immunology and molecular biology-related keywords were frequently used before 2012, more clinical (treatment outcome, antimicrobial stewardship, antimicrobial resistance) and environmental cluster-related keywords appeared later, with a low occurrence of resistance and the One Health concept.
Conclusion
This study assessed research productivity related to antimicrobials from Lebanese institutions; it showed the need for greater public sector involvement, expanded national and international research collaborations, and increased focus on critical concepts such as antimicrobial resistance and the One Health approach. Future studies should evaluate research quality and expand the search to additional research platforms other than PubMed for a more comprehensive understanding of the Lebanese research productivity in this field and further optimize strategic measures to combat antimicrobial resistance, optimize research agenda, and improve patient health outcomes.
{"title":"Antimicrobial research productivity in Lebanon: A PubMed-Based bibliometric analysis","authors":"Aline Hajj , Hala Sacre , Maria Ounsi , Mariam Nasser , Sara Mohsen Meame , Hussein Hazime , Amal Al-Hajje , Deema Rahme , Nathalie Lahoud , Jihan Safwan , Marwan Akel , Rony M. Zeenny , Katia Iskandar , Pascale Salameh","doi":"10.1016/j.nmni.2025.101642","DOIUrl":"10.1016/j.nmni.2025.101642","url":null,"abstract":"<div><h3>Background</h3><div>Antimicrobials have revolutionized medicine globally, but emerging antimicrobial resistance due to antimicrobial misuse might revert the world to the “pre-antibiotic era”. Research on the topic contributes to fighting antimicrobial resistance and developing related strategies. Hence, this bibliometric analysis aimed to assess antimicrobial research productivity in Lebanon.</div></div><div><h3>Methods</h3><div>Relevant publications were retrieved from PubMed, and data were assessed using the VOS viewer. The most research-active institutions, collaboration patterns, and various antimicrobial research areas were reported and discussed.</div></div><div><h3>Results</h3><div>Research productivity has exhibited an increasing trend over the past 20 years. Private institutions were the most active (90%), while international collaborations were moderate (40%), mainly with institutions in the United States and France. The only visible public-private partnership involved collaboration between the Lebanese University and other institutions. While immunology and molecular biology-related keywords were frequently used before 2012, more clinical (treatment outcome, antimicrobial stewardship, antimicrobial resistance) and environmental cluster-related keywords appeared later, with a low occurrence of resistance and the One Health concept.</div></div><div><h3>Conclusion</h3><div>This study assessed research productivity related to antimicrobials from Lebanese institutions; it showed the need for greater public sector involvement, expanded national and international research collaborations, and increased focus on critical concepts such as antimicrobial resistance and the One Health approach. Future studies should evaluate research quality and expand the search to additional research platforms other than PubMed for a more comprehensive understanding of the Lebanese research productivity in this field and further optimize strategic measures to combat antimicrobial resistance, optimize research agenda, and improve patient health outcomes.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101642"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145268558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-09-11DOI: 10.1016/j.nmni.2025.101639
Nitin Gupta , Sonali Singh , Tirlangi Praveen Kumar , Sundeep Malla , Astha Sethi , Carl Boodman , Steven Van Den Broucke , Erika Vlieghe , Emmanuel Bottieau , Martin Peter Grobusch , Chiranjay Mukhopadhyay
Background
Neuromelioidosis can present with abscesses, meningitis, or encephalomyelitis, but can be missed on blood culture. Linear enhancement of the corticospinal tract (white matter motor pathway) on magnetic resonance imaging (MRI) in the form of a ‘tunnel sign’ is an essential clue for early diagnosis of neuromelioidosis. This systematic review (SR) explores the clinical profile and outcomes of neuromelioidosis patients with tunnel signs.
Methods
An SR was conducted to look for articles reporting individual details of neuromelioidosis patients with tunnel signs (reported or present on published images) on MRI. This review followed PRISMA guidelines and was prospectively registered with PROSPERO (CRD42024597199). After title-abstract and full-text screening, clinical profile and outcome data were extracted and analysed.
Results
Thirty cases (22 articles) with tunnel signs on MRI were included after screening 2985 articles. The traditional risk factors (diabetes mellitus, alcohol intake, steroids, etc.) for melioidosis were present in only 23 % (5/22) of patients. Limb weakness (89 %, 24/27) and cranial nerve involvement (46 %, 11/24) were commonly seen at presentation. Blood and cerebrospinal fluid (CSF) cultures for B.pseudomallei were only positive in 15 % (2/13) and 22 % (4/18). Due to low rates of clinical suspicion of neuromelioidosis (25 %, 6/24), empirical steroids and inappropriate antimicrobials were given in 47 % (8/17) and 65 % (9/17) of patients, respectively. A total of 30 % (n = 9) of the patients died.
Conclusion
In melioidosis-endemic areas with access to MRI, recognising the link between the presence of a tunnel sign and neuromelioidosis is crucial to initiate early adequate therapy.
{"title":"Tunnel sign on magnetic resonance imaging in neuromelioidosis: A systematic literature review","authors":"Nitin Gupta , Sonali Singh , Tirlangi Praveen Kumar , Sundeep Malla , Astha Sethi , Carl Boodman , Steven Van Den Broucke , Erika Vlieghe , Emmanuel Bottieau , Martin Peter Grobusch , Chiranjay Mukhopadhyay","doi":"10.1016/j.nmni.2025.101639","DOIUrl":"10.1016/j.nmni.2025.101639","url":null,"abstract":"<div><h3>Background</h3><div>Neuromelioidosis can present with abscesses, meningitis, or encephalomyelitis, but can be missed on blood culture. Linear enhancement of the corticospinal tract (white matter motor pathway) on magnetic resonance imaging (MRI) in the form of a ‘tunnel sign’ is an essential clue for early diagnosis of neuromelioidosis. This systematic review (SR) explores the clinical profile and outcomes of neuromelioidosis patients with tunnel signs.</div></div><div><h3>Methods</h3><div>An SR was conducted to look for articles reporting individual details of neuromelioidosis patients with tunnel signs (reported or present on published images) on MRI. This review followed PRISMA guidelines and was prospectively registered with PROSPERO (CRD42024597199). After title-abstract and full-text screening, clinical profile and outcome data were extracted and analysed.</div></div><div><h3>Results</h3><div>Thirty cases (22 articles) with tunnel signs on MRI were included after screening 2985 articles. The traditional risk factors (diabetes mellitus, alcohol intake, steroids, etc.) for melioidosis were present in only 23 % (5/22) of patients. Limb weakness (89 %, 24/27) and cranial nerve involvement (46 %, 11/24) were commonly seen at presentation. Blood and cerebrospinal fluid (CSF) cultures for <em>B.pseudomallei</em> were only positive in 15 % (2/13) and 22 % (4/18). Due to low rates of clinical suspicion of neuromelioidosis (25 %, 6/24), empirical steroids and inappropriate antimicrobials were given in 47 % (8/17) and 65 % (9/17) of patients, respectively. A total of 30 % (n = 9) of the patients died.</div></div><div><h3>Conclusion</h3><div>In melioidosis-endemic areas with access to MRI, recognising the link between the presence of a tunnel sign and neuromelioidosis is crucial to initiate early adequate therapy.</div></div>","PeriodicalId":38074,"journal":{"name":"New Microbes and New Infections","volume":"68 ","pages":"Article 101639"},"PeriodicalIF":5.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145050426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}